These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9213036)

  • 1. Pharmacokinetics and tissue localization of antisense oligonucleotides in balloon-injured pig coronary arteries after local delivery with an iontophoretic balloon catheter.
    Robinson KA; Chronos NA; Schieffer E; Palmer SJ; Cipolla GD; Milner PG; Walsh RG; King SB
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):354-9. PubMed ID: 9213036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized delivery of heparin to angioplasty sites with iontophoresis.
    Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of c-myb antisense oligonucleotides during balloon angioplasty.
    Azrin MA; Mitchel JF; Bow LM; Pedersen CA; Cartun RW; Aretz TH; Waters DD; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):232-40. PubMed ID: 9213020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltrator Angioplasty Balloon Catheter: a device for combined angioplasty and intramural site-specific treatment.
    Barath P; Popov A; Dillehay GL; Matos G; McKiernan T
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):333-41. PubMed ID: 9213033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoluminal local delivery of PCNA/cdc2 antisense oligonucleotides by porous balloon catheter does not affect neointima formation or vessel size in the pig coronary artery model of postangioplasty restenosis.
    Robinson KA; Chronos NA; Schieffer E; Palmer SJ; Cipolla GD; Milner PG; King SB
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):348-53. PubMed ID: 9213035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model.
    Fram DB; Mitchel JF; Azrin MA; Chow MS; Waters DD; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):275-86. PubMed ID: 9213026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local urokinase delivery with the Channel balloon: device safety, pharmacokinetics of intracoronary drug delivery, and efficacy of thrombolysis.
    Mitchel JF; Barry JJ; Bow L; Alberghini TA; Abbas SA; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):254-60. PubMed ID: 9213023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries.
    Lambert DL; Malik N; Shepherd L; Gunn J; Francis SE; King A; Crossman DC; Cumberland DC; Holt CM
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1727-32. PubMed ID: 11701457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained local drug delivery to the arterial wall via biodegradable microspheres.
    Dev V; Eigler N; Fishbein MC; Tian Y; Hickey A; Rechavia E; Forrester JS; Litvack F
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):324-32. PubMed ID: 9213032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach for local intravascular drug delivery. Iontophoretic balloon.
    Fernández-Ortiz A; Meyer BJ; Mailhac A; Falk E; Badimon L; Fallon JT; Fuster V; Chesebro JH; Badimon JJ
    Circulation; 1994 Apr; 89(4):1518-22. PubMed ID: 8149516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative evaluation of local drug delivery using the InfusaSleeve catheter.
    Gottsauner-Wolf M; Jang Y; Penn MS; Kaplan A; Ellis SG; Chisolm GM; Topol EJ; Lincoff AM
    Cathet Cardiovasc Diagn; 1997 Sep; 42(1):102-8. PubMed ID: 9286553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramural drug delivery by direct injection within the arterial wall: first clinical experience with a novel intracoronary delivery-infiltrator system.
    Pavlides GS; Barath P; Maginas A; Vasilikos V; Cokkinos DV; O'Neill WW
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):287-92. PubMed ID: 9213027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty.
    Gunn J; Holt CM; Francis SE; Shepherd L; Grohmann M; Newman CM; Crossman DC; Cumberland DC
    Circ Res; 1997 Apr; 80(4):520-31. PubMed ID: 9118483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of smooth muscle cell proliferation after local drug delivery of low-molecular-weight heparin using a porous balloon catheter.
    Oberhoff M; Herdeg C; Baumbach A; Shamet K; Kranzhöfer A; Weingärtner O; Rübsamen K; Kluge M; Karsch KR
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):268-74. PubMed ID: 9213025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-molecular-weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery.
    Baumbach A; Oberhoff M; Bohnet A; Miljak T; Herdeg C; Horch B; Blessing E; Kunert W; Haase KK; Karsch KR
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):303-7. PubMed ID: 9213029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local drug delivery with porous balloons in the rabbit: assessment of vascular injury for an improvement of application parameters.
    Herdeg C; Oberhoff M; Baumbach A; Haase KK; Horch B; Kranzhoefer A; Karsch KR
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):308-14. PubMed ID: 9213030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous balloon delivery of low molecular weight heparin in the dog coronary artery.
    Baumbach A; Oberhoff M; Rübsamen K; Jochims K; Herdeg C; Kranzhöfer A; Safer A; Karsch KR
    Eur Heart J; 1996 Oct; 17(10):1538-45. PubMed ID: 8909911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A total delivery system of genetically engineered drugs or cells for diseased vessels. Concept, materials, and fabricated prototype device.
    Kito H; Suzuki T; Nagahara S; Nakayama Y; Tsutsui Y; Isutsui N; Nakajima N; Matsuda T
    ASAIO J; 1994; 40(3):M260-6. PubMed ID: 8555521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter-based local thrombolysis with urokinase: comparative efficacy of intraluminal clot lysis with conventional urokinase infusion techniques in an in vivo porcine thrombus model.
    Mitchel JF; Shwedick M; Alberghini TA; Knibbs D; McKay RG
    Cathet Cardiovasc Diagn; 1997 Jul; 41(3):293-302. PubMed ID: 9213028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent-based delivery of antisense oligodeoxynucleotides targeted to the PDGF A-chain decreases in-stent restenosis of the coronary artery.
    Li Y; Fukuda N; Kunimoto S; Yokoyama S; Hagikura K; Kawano T; Takayama T; Honye J; Kobayashi N; Mugishima H; Saito S; Serie K
    J Cardiovasc Pharmacol; 2006 Oct; 48(4):184-90. PubMed ID: 17086098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.